Salvage brachytherapy for locally recurrent prostate cancer after definitive radiotherapy - a multicentric French cohort by the SFRO brachytherapy group.

Date publication

septembre 2025

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr MARTIN Etienne

Tous les auteurs :
Kissel M, Ka K, Meraouna Y, Terlizzi M, Schiappa R, Hannoun-Levi JM, Hanaya S, Serre AA, Sarr O, Verry C, Khoukaz A, Martin E, Cosset JM, Blanchard P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41038281

Résumé

Salvage brachytherapy (BT) after definitive irradiation for prostate cancer is gaining increasing interest, although many areas of uncertainty remain.

Mots clés

Brachytherapy, High-dose rate, Iodine seeds, Prostatic neoplasms, Re-irradiation, Salvage therapy

Référence

Radiother Oncol. 2025 09 30;213:111170